Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $12.2800 (3.76%) ($12.2800 - $12.2800) on Wed. Dec. 13, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.39% (three month average) | RSI | 78 | Latest Price | $12.2800(3.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD advances 2.2% a day on average for past five trading days. | Weekly Trend | FOLD advances 4.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) QQQ(83%) TAN(73%) XBI(70%) IBB(68%) VT(68%) | Factors Impacting FOLD price | FOLD will decline at least -1.695% in a week (0% probabilities). EDOC(-78%) XLE(-25%) VIXM(-19%) UUP(-15%) URA(-15%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.695% (StdDev 3.39%) | Hourly BBV | 2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $11.65(5.41%) | 10 Day Moving Average | $11.39(7.81%) | 20 Day Moving Average | $11.06(11.03%) | To recent high | -6.4% | To recent low | 23.2% | Market Cap | $3.171b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |